The MIND-TD Faculty have been compensated by Neurocrine Biosciences, Inc.
Guidelines and Consensus on Screening and Treatment of Tardive Dyskinesia
Presentation
~2 mins
Oct 2022
1 of 6
Interactive
~5 mins
Dec 2022
Video
~3 mins
Nov 2022
This site contains information intended only for US healthcare professionals involved in the management of people with tardive dyskinesia.
This website is part of a disease-awareness, non-CME program sponsored by Neurocrine Biosciences, Inc.